
    
      Approximately 75 male and female patients with schizophrenia or schizoaffective disorder on
      antipsychotic maintenance medication will be enrolled into the study. There will be 4 planned
      cohorts of 14 patients per cohort.

      In Cohorts 1-3, patients' planned participation in the study is for a total of approximately
      22 weeks, including a Screening period of up to 35 days, and a study treatment period of 120
      days (including follow-up).

      In Cohort 4 planned participation in the study is for a total of approximately 18 weeks
      including a Screening period of up to 35 days and a study treatment of 92 days (including
      follow-up).
    
  